> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears Bone Index Osteoporosis Diagnostic
- URL: https://www.fdaweb.com/fda-clears-bone-index-osteoporosis-diagnostic-2/
- Published: 2017-01-20T12:00:00.000Z
- Updated: 2026-09-14T22:02:05.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5137784

FDA has cleared a Bone Index Ltd. 510(k) for its second generation Bindex point-of-care device model to help in osteoporosis diagnosis. The device measures the cortical bone thickness of the tibia and its algorithm calculates a “Density Index,” a parameter which estimates bone mineral density at the hip as measured with a DXA x-ray machine, according to the company. Bindex detects osteoporosis with 90% sensitivity and specificity, it adds.